RANBP9

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RANBP9 mutation is significantly associated with the RNA expression of many other genes, with 2,158 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible RANBP9-associated genes across cancer lineages are CSGALNACT2P2, RNA5SP453, and CLRN1. Each is linked with RANBP9 in more than 1 cancer types. Because this analysis shows association rather than direction, both RANBP9-to-partner and partner-to-RANBP9 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, CSGALNACT2P2 grouped by RANBP9-low versus RANBP9-high in PRAD.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (RANBP9→partner) and Y-score (partner→RANBP9) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
PRADCSGALNACT2P2 →+0.164+5.288<.001.00632
SKCMRNA5SP453 →+0.207+4.385<.001.00832
SCLCCLRN1 →+0.995+4.502.002.00431
BLCAOTOL1 →+0.317+3.883<.001.00631
BLCAOR5G5P →+0.082+4.213<.001.00331
BLCARNU6-1181P →+0.228+4.562<.001.00631
Each partner links to its Q-omics profile. Showing the 6 strongest of 2,158 associations by consensus.

CSGALNACT2P2 by RANBP9 expression — PRAD

Box plot of CSGALNACT2P2 in RANBP9-low vs RANBP9-high samples in PRAD.

Explore this box plot interactively →

Exploration